Elligo Health Research is a startup operating at the intersection of healthcare and clinical research. The company's primary function is to facilitate clinical trials by providing direct access to healthcare-first sites, elite research sites, and research-enhancing study-level services. They also offer clinical trial management solutions aimed at reducing risk and increasing certainty.

Elligo's clientele is diverse, including hospitals, major health systems, and research-only sites. The company boasts a network of 115 hospitals and major health systems, 200 healthcare-based research sites, and 100 research-only sites. This broad network allows Elligo to serve a wide range of clients, from small healthcare providers to large research institutions.

The company operates in the global clinical trials market, which involves testing new drugs and treatments on patients in a controlled and regulated environment. In the past year, Elligo has supported over 1,000 studies for more than 80 sponsors or Contract Research Organizations (CROs) across 30 countries in over 15 therapeutic areas.

Elligo's business model revolves around providing services to these sponsors or CROs. They charge for access to their network of healthcare and research sites, as well as for their clinical trial management solutions. This revenue model allows Elligo to generate income while also contributing to the advancement of medical research.

In summary, Elligo Health Research is a facilitator of clinical trials, providing access to a wide network of healthcare and research sites, and offering clinical trial management solutions. Their services are used by a diverse range of clients, from hospitals to research institutions, and they operate in the global clinical trials market.

Keywords: Clinical Trials, Healthcare, Research Sites, Clinical Trial Management, Risk Reduction, Certainty Increase, Global Market, Diverse Clients, Revenue Model, Medical Research.